Steven M. Levine

Steven M. Levine

Auto-generated profile, based on publicly available information

Steven M. Levine

Dassault Systèmes

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2024 in Clinical Microbiology Reviews
Verified
Journal Article
Closed access
JCJaclyn A. Cusumano
Jaclyn A. Cusumano
Andreas KalogeropoulosAndreas Kalogeropoulos
Andreas Kalogeropoulos
MPMathieu Le Provost
Mathieu Le Provost
NGNicolas R. Gallo
Nicolas R. Gallo
SLSteven M. Levine
Steven M. Levine
APAikaterini Papamanoli
Aikaterini Papamanoli
SUMMARY: Infective endocarditis (IE) is a life-threatening infection that has nearly doubled in prevalence over the last two decades due to the increase in implantable cardiac devices. Transcatheter aortic valve implantation (TAVI) is currently one of the most common cardiac procedures. TAVI usage continues to exponentially rise, inevitability increasing TAVI-IE. Patients with TAVI are frequently nonsurgical candidates, and TAVI-IE 1-year mortality rates can be as high as 74% without valve or bacterial biofilm removal. Enterococcus faecalis, a historically less common IE pathogen, is the primary cause of TAVI-IE. Treatment options are limited due to enterococcal intrinsic resistance and biofilm formation. Novel approaches are warranted to tackle current therapeutic gaps. We describe the existing challenges in treating TAVI-IE and how available treatment discovery approaches can be combined with an in silico “Living Heart” model to create solutions for the future.